Jubilee Brown

Clinical Activity and Safety of the Anti–Programmed Death 1 Monoclonal Antibody Dostarlimab for Patients With Recurrent or Advanced Mismatch Repair–Deficient Endometrial Cancer

Ana Oaknin, Anna V. Tinker, Lucy Gilbert et al. · JAMA Oncology · 2020 · 357 citations · Full text

Medicine, Oncology, Pharmacology +16

Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET—a phase I, single-arm study

Ana Oaknin, Lucy Gilbert, Anna V. Tinker et al. · Journal for ImmunoTherapy of Cancer · 2022 · 322 citations · Full text

Medicine, Oncology, Pharmacology +15

Comparison of Total Laparoscopic and Abdominal Radical Hysterectomy for Patients With Early-Stage Cervical Cancer

Michael Frumovitz, Ricardo dos Reis, Charlotte C. Sun et al. · Obstetrics and Gynecology · 2007 · 254 citations

Medicine, Oncology, Surgery +15

Patterns of metastasis in sex cord-stromal tumors of the ovary: Can routine staging lymphadenectomy be omitted?

Jubilee Brown, Anil K. Sood, Michael T. Deavers et al. · Gynecologic Oncology · 2009 · 182 citations

Medicine, Oncology, Surgery +12

The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors

Jubilee Brown, Hyun S. Shvartsman, Michael T. Deavers et al. · Gynecologic Oncology · 2005 · 138 citations

Medicine, Gynecology, Oncology +11